What investment strategy does OBRATORI, L'Occitane Group Ventures focus on?

OBRATORI, L'Occitane Group Ventures focuses on VC strategies in the private equity space.

How many portfolio companies does OBRATORI, L'Occitane Group Ventures have?

OBRATORI, L'Occitane Group Ventures has 26 active portfolio companies and 1 completed exit and 1 fund tracked on GP Intel.

Where is OBRATORI, L'Occitane Group Ventures headquartered?

OBRATORI, L'Occitane Group Ventures is headquartered in Marseille, France.

What is OBRATORI, L'Occitane Group Ventures's assets under management?

OBRATORI, L'Occitane Group Ventures manages approximately €30M in assets under management.

When was OBRATORI, L'Occitane Group Ventures founded?

OBRATORI, L'Occitane Group Ventures was founded in 2019.

What sectors does OBRATORI, L'Occitane Group Ventures invest in?

OBRATORI, L'Occitane Group Ventures invests across Consumer, Healthcare, Industrials.

What are OBRATORI, L'Occitane Group Ventures's recent exits?

Recent realized exits by OBRATORI, L'Occitane Group Ventures include: Ma Formation Medicale (2023) to Institut de Thérapie Manuelle et Physiothérapie (ITMP).

Home/GPs/OBRATORI, L'Occitane Group Ventures

DetailCard

OBRATORI, L'Occitane Group Ventures

Marseille, France·Founded 2019·

Venture Capital

·obratori.com

Corporate venture capital arm of L'Occitane Group, the Manosque-based premium natural beauty group behind L'Occitane en Provence, Melvita, Erborian and, since 2021, Sol de Janeiro. Founded in 2019 in Marseille, it makes early-stage seed and Series A investments across sustainable beauty, biotech, clean cosmetics, e-health, wellbeing, plant-based actives, foodtech and retailtech under its 'Better for people and for the planet' criterion. The portfolio counts 15 active companies as of 2026, out of 22 cumulative investments, with no confirmed exits to date; the 2019-vintage program remains in active deployment.

AUM

€30M

Funds

vintages 2019

Portfolio

Exits

OBRATORI, L'Occitane Group Ventures is a Marseille venture capital firm with €30M AUM, 26 active companies and 1 exit.

SectorsConsumer Healthcare Industrials

Sector breakdown

27 companies

Consumer

7 · 26%

ClimateTech

2 · 7%

SaaS

2 · 7%

HealthTech

2 · 7%

Biotech

1 · 4%

Fintech

1 · 4%

Key facts

HQMarseille, France

Founded2019

Websiteobratori.com

Recent exits

OBRATORI, L'Occitane Group Ventures sold Ma Formation Medicale to Institut de Thérapie Manuelle et Physiothérapie (ITMP) in 2023 after 4 years.

Coverage notes

1 fund tracked, 27 portfolio companies (26 active · 1 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund OBRATORI, L'Occitane Group Ventures has raised, with its portfolio companies. Hand-checked from public filings.

1 fund

Fund

Strategy

Vintage

Size

Assets

Exits

Obratori

VC2019€30M26 assets1 exits

2019 · 7yr

€30M

Unrealized

26 held

Company	Entry
Abyssea	2019
Bocoloco	2019
Calysens Biotech · France	2021
Carton Vert ClimateTech · France	2023
ClearDrop/ClearSolar France	2024
Cliking	2019
Eclo	2019
FunCell ClimateTech · France	2022
Good Meal SaaS · France	2022
Healphi HealthTech · France	2018
HedonistLabs	2019
Humble + Consumer · France	2024
In Haircare Consumer · France	2022
KohortPay Fintech · France	2023
Lazare Studio Consumer · France	2024
LE Rouge Francais Consumer · France	2019
Leo et Violette	2019
Lolo Paris Consumer · France	2021
Ma Blouse Blanche	2019
Medene	2019
Melifera Consumer · France	2021
MonSuiviDiet HealthTech · France	2022
Paper Cosmetics Consumer · France	2021
Plasana Medical France	2025
Sweetech France	2025
Zeliq SaaS · France	2023

Realized

1 exit

Company	Entry	Exit	Type	Buyer	MOIC
Ma Formation Medicale	2019	2023	Trade Sale	Institut de Thérapie Manuelle et Physiothérapie (ITMP)	–

About OBRATORI, L'Occitane Group Ventures

OBRATORI, L'Occitane Group Ventures is a venture capital platform based in Paris with capital deployed across 2 active fund vehicles. The firm targets European and selectively global technology companies across consumer, healthcare and business services, with capital deployed across early-stage and Series A/B rounds alongside institutional limited partners.

Investment thesis

The platform deploys venture capital into consumer, healthcare and business services categories with a focus on technology-enabled businesses across France and selectively across Europe. Investment focus spans seed and growth stages with capital deployed across multiple rounds per portfolio company, supporting founder teams through international scaling and selective M&A activity. The fund structure enables longer holding periods than typical venture vehicles, supporting category-leadership outcomes in technology platforms with global ambitions.

Recent activity

Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 16 active portfolio companies and 0 realised exits across the strategy's history.

Frequently asked questions

What investment strategy does OBRATORI, L'Occitane Group Ventures focus on?: OBRATORI, L'Occitane Group Ventures focuses on VC strategies in the private equity space.
How many portfolio companies does OBRATORI, L'Occitane Group Ventures have?: OBRATORI, L'Occitane Group Ventures has 26 active portfolio companies and 1 completed exit and 1 fund tracked on GP Intel.
Where is OBRATORI, L'Occitane Group Ventures headquartered?: OBRATORI, L'Occitane Group Ventures is headquartered in Marseille, France.
What is OBRATORI, L'Occitane Group Ventures's assets under management?: OBRATORI, L'Occitane Group Ventures manages approximately €30M in assets under management.
When was OBRATORI, L'Occitane Group Ventures founded?: OBRATORI, L'Occitane Group Ventures was founded in 2019.
What sectors does OBRATORI, L'Occitane Group Ventures invest in?: OBRATORI, L'Occitane Group Ventures invests across Consumer, Healthcare, Industrials.
What are OBRATORI, L'Occitane Group Ventures's recent exits?: Recent realized exits by OBRATORI, L'Occitane Group Ventures include: Ma Formation Medicale (2023) to Institut de Thérapie Manuelle et Physiothérapie (ITMP).